Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial

Timo Vesikari; Aino Karvonen; Veronique Bianco; Marie Van der Wielen; M van DER Wielen; Jacqueline Miller

doi:10.1016/j.vaccine.2011.03.043

Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial

Timo Vesikari, Aino Karvonen, Veronique Bianco, Marie Van der Wielen, M van DER Wielen, Jacqueline Miller

Research output: Contribution to journal › Article › Scientific › peer-review

71 Citations (Scopus)

Original language	English
Pages (from-to)	4274-4284
Journal	VACCINE
Volume	29
Issue number	25
DOIs	https://doi.org/10.1016/j.vaccine.2011.03.043
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

Keywords

Bactericidal activity
Conjugate vaccine
Measlesmumpsrubellavaricella vaccine
Tetravalent meningococcal vaccine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2011.03.043

Cite this

Vesikari, T., Karvonen, A., Bianco, V., Van der Wielen, M., van DER Wielen, M., & Miller, J. (2011). Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial. VACCINE, 29(25), 4274-4284. https://doi.org/10.1016/j.vaccine.2011.03.043

@article{c46ac519447b49809e19e25d8ad4ffe5,

title = "Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial",

keywords = "Bactericidal activity, Conjugate vaccine, Measlesmumpsrubellavaricella vaccine, Tetravalent meningococcal vaccine, Bactericidal activity, Conjugate vaccine, Measlesmumpsrubellavaricella vaccine, Tetravalent meningococcal vaccine",

author = "Timo Vesikari and Aino Karvonen and Veronique Bianco and \{Van der Wielen\}, Marie and \{van DER Wielen\}, M and Jacqueline Miller",

year = "2011",

doi = "10.1016/j.vaccine.2011.03.043",

language = "English",

volume = "29",

pages = "4274--4284",

journal = "VACCINE",

issn = "0264-410X",

publisher = "Elsevier",

number = "25",

}

Vesikari, T, Karvonen, A, Bianco, V, Van der Wielen, M, van DER Wielen, M & Miller, J 2011, 'Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial', VACCINE, vol. 29, no. 25, pp. 4274-4284. https://doi.org/10.1016/j.vaccine.2011.03.043

Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial. / Vesikari, Timo; Karvonen, Aino; Bianco, Veronique et al.
In: VACCINE, Vol. 29, No. 25, 2011, p. 4274-4284.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial

AU - Vesikari, Timo

AU - Karvonen, Aino

AU - Bianco, Veronique

AU - Van der Wielen, Marie

AU - van DER Wielen, M

AU - Miller, Jacqueline

PY - 2011

Y1 - 2011

KW - Bactericidal activity

KW - Conjugate vaccine

KW - Measlesmumpsrubellavaricella vaccine

KW - Tetravalent meningococcal vaccine

KW - Bactericidal activity

KW - Conjugate vaccine

KW - Measlesmumpsrubellavaricella vaccine

KW - Tetravalent meningococcal vaccine

U2 - 10.1016/j.vaccine.2011.03.043

DO - 10.1016/j.vaccine.2011.03.043

M3 - Article

SN - 0264-410X

VL - 29

SP - 4274

EP - 4284

JO - VACCINE

JF - VACCINE

IS - 25

ER -

Vesikari T, Karvonen A, Bianco V, Van der Wielen M, van DER Wielen M, Miller J. Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life : an open, randomized controlled trial. VACCINE. 2011;29(25):4274-4284. doi: 10.1016/j.vaccine.2011.03.043